Peter Bias
Impact in
- Oncology top 10%
- Neutropenia and Cancer Infections
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
Papers in
- Co-authors
- Anton Buchner (22 shared papers)Stefan Laufer (3 shared papers)Oleg Gladkov (10 shared papers)Christoph Behrens (6 shared papers)Igor Bondarenko (7 shared papers)T. Strowitzki (2 shared papers)Waldemar Kuczyński (2 shared papers)Boulos Haraoui (2 shared papers)
In The Last Decade
Peter Bias
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Oncology 302
- Rheumatology 150
- Reproductive Medicine 78
- Genetics 235
- Hematology 86
Countries citing papers authored by Peter Bias
This map shows the geographic impact of Peter Bias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bias more than expected).
Fields of papers citing papers by Peter Bias
This network shows the impact of papers produced by Peter Bias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bias. The network helps show where Peter Bias may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bias, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 139 | |
| 2 | 2004 | 81 | |
| 3 | 2005 | 79 | |
| 4 | 2013 | 76 | |
| 5 | 2007 | 73 | |
| 6 | 2016 | 71 | |
| 7 | 2009 | 51 | |
| 8 | 2020 | 44 | |
| 9 | 2003 | 39 | |
| 10 | 2008 | 32 | |
| 11 | 2009 | 31 | |
| 12 | 2014 | 29 | |
| 13 | 2004 | 26 | |
| 14 | 2013 | 22 | |
| 15 | 2001 | 22 | |
| 16 | 2016 | 21 | |
| 17 | 2010 | 19 | |
| 18 | 2014 | 18 | |
| 19 | 2015 | 17 | |
| 20 | First clinical results of licofelone (ml3000), an inhibitor of COX-1, COX-2 and 5-LOX, for the treatment of osteoarthritis | 2002 | 14 |
About Peter Bias
Peter Bias is a scholar working on Oncology, Genetics, Hematology, Molecular Biology and Pharmacology, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (20 papers), Blood disorders and treatments (8 papers), Erythropoietin and Anemia Treatment (5 papers), Ovarian function and disorders (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Inflammatory mediators and NSAID effects (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (302 citations), Rheumatology (150 citations), Reproductive Medicine (78 citations), Genetics (235 citations) and Hematology (86 citations). Peter Bias has collaborated with scholars based in Germany, Russia and Ukraine. Frequent co-authors include Anton Buchner, Stefan Laufer, Oleg Gladkov, Christoph Behrens, Igor Bondarenko, T. Strowitzki, Waldemar Kuczyński, Boulos Haraoui, D. Choquette and Johanne Martel‐Pelletier. Their work appears in journals such as Supportive Care in Cancer, Journal of Clinical Oncology, Current Medical Research and Opinion, Reproductive Biology and Endocrinology and BioDrugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.